-+ 0.00%
-+ 0.00%
-+ 0.00%

KAILERA THERAPEUTICS - PHASE 2 RIBUPATIDE ORAL SHOWS UP TO 12.1% MEAN WEIGHT LOSS AT 26 WEEKS

Reuters·06/05/2026 23:37:51

Please log in to view news